The vision of the CCNA is to bring together 20 research teams involving over 340 top Canadian researchers in the field of neurodegenerative diseases affecting cognition such as Alzheimer's in a collaborative and synergistic space. Researchers will work on bold and transformative research ideas to make a difference in the quality of life and the quality of services for those living with dementia and their caregivers.
To promote high impact, the CCNA will include inter-institutional and interdisciplinary collaboration. Researchers will work with key stakeholders such as patients and their families.
Research within the CCNA will be organized around three research themes aimed at preventing and mitigating the toll of dementia and related neurodegenerative diseases of aging for individuals and society.
The three themes are:
- Primary Prevention – aimed at preventing the disease from developing;
- Secondary Prevention – focused on delaying the clinical manifestations of the already developing disease; and
- Quality of Life – designed for helping individuals, caregivers and the health system in the context of a clinically developed disease.
The CCNA is a $31.5M investment from the Government of Canada through the Canadian Institutes of Health Research, and many important partners. The CCNA researchers will also benefit from an additional $24M investment by a subset of the partners in Ontario and Quebec.
